TLRY logo

Tilray Brands, Inc. (TLRY)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Tilray Brands, Inc. (TLRY) trades at $6.54 with AI Score 47/100 (Weak). Tilray Brands, Inc. is a global cannabis-lifestyle CPG company. Market cap: 663M, Sector: Healthcare.

Last analyzed: Feb 5, 2026
Tilray Brands, Inc. is a global cannabis-lifestyle CPG company. The company cultivates, produces, markets, and distributes medical and adult-use cannabis, beverage alcohol, and wellness products across multiple international markets.
47/100 AI Score Target $10.00 (+52.9%) MCap 663M Vol 2M

Tilray Brands, Inc. (TLRY) Healthcare & Pipeline Overview

CEOIrwin David Simon
Employees2650
HeadquartersLeamington, ON, CA
IPO Year2018

Tilray Brands, Inc. (TLRY) is a leading global cannabis-lifestyle CPG company with a diverse portfolio of cannabis, beverage alcohol, and wellness products, poised for growth through strategic acquisitions, international expansion, and favorable regulatory shifts, despite current profitability challenges.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 5, 2026

Investment Thesis

Tilray presents a notable research candidate based on its strategic positioning in the rapidly evolving cannabis and beverage alcohol markets. The company's diverse portfolio, including established cannabis brands and craft beverage alcohol offerings, provides multiple avenues for revenue growth. Key value drivers include the potential for cannabis legalization in the U.S. and Europe, which would significantly expand Tilray's market reach. Furthermore, strategic acquisitions and cost synergies are expected to improve profitability. While current profitability is a concern with a negative profit margin of -252.6%, anticipated revenue growth and cost optimization efforts could drive improved financial performance in the coming years. Investors should monitor regulatory developments and Tilray's ability to execute its growth strategy effectively.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $0.77B reflects the company's current valuation in a volatile market.
  • Gross Margin of 28.0% indicates the profitability of Tilray's core operations before operating expenses.
  • P/E Ratio of -0.28 suggests the company is currently unprofitable, requiring careful monitoring of future earnings.
  • Beta of 2.11 indicates higher volatility compared to the overall market, reflecting the speculative nature of the cannabis industry.
  • Tilray operates in multiple international markets, providing diversification and exposure to varying regulatory environments.

Competitors & Peers

Strengths

  • Diversified product portfolio across cannabis, beverage alcohol, and wellness.
  • Established brands with strong market recognition.
  • International presence with operations in multiple countries.
  • Strategic partnerships and distribution networks.

Weaknesses

  • Negative profit margin and ongoing losses.
  • High debt levels.
  • Dependence on regulatory changes in the cannabis industry.
  • Intense competition in the cannabis and beverage alcohol markets.

Catalysts

  • Upcoming: Potential cannabis legalization in key U.S. states and European countries.
  • Ongoing: Expansion of distribution networks and strategic partnerships.
  • Ongoing: Development and launch of new cannabis-infused products.
  • Ongoing: Cost optimization and synergy realization from acquisitions.

Risks

  • Potential: Regulatory setbacks and delays in cannabis legalization.
  • Ongoing: Intense competition and price pressures in the cannabis market.
  • Ongoing: Fluctuations in cannabis prices and demand.
  • Potential: Economic downturns affecting consumer spending on cannabis and beverage alcohol products.
  • Ongoing: High debt levels and potential financial distress.

Growth Opportunities

  • Growth opportunity 1: Expansion into the U.S. cannabis market represents a significant growth opportunity for Tilray. With potential federal legalization on the horizon, Tilray is positioning itself to capitalize on this market through strategic partnerships and acquisitions. The U.S. cannabis market is estimated to be worth billions of dollars, offering substantial revenue potential for Tilray. Timeline: Ongoing, with potential acceleration upon federal legalization.
  • Growth opportunity 2: International expansion, particularly in Europe, offers another avenue for growth. Several European countries are considering or have already legalized medical or recreational cannabis, creating new market opportunities for Tilray's cannabis products. The European cannabis market is projected to grow significantly in the coming years. Timeline: Ongoing, with phased expansion into key European markets.
  • Growth opportunity 3: Strategic acquisitions of complementary businesses can enhance Tilray's product portfolio and market reach. By acquiring companies in the beverage alcohol or wellness sectors, Tilray can diversify its revenue streams and leverage synergies across its operations. Timeline: Ongoing, with potential acquisitions in the near to medium term.
  • Growth opportunity 4: Development of innovative cannabis-infused products can drive revenue growth and differentiate Tilray from its competitors. By focusing on research and development, Tilray can create new products that appeal to consumers and capture market share. Timeline: Ongoing, with continuous product development efforts.
  • Growth opportunity 5: Leveraging its existing distribution network to expand the reach of its beverage alcohol brands represents a synergistic growth opportunity. By utilizing its established distribution channels, Tilray can increase the sales and market share of its beverage alcohol products. Timeline: Ongoing, with focused efforts to expand distribution partnerships.

Opportunities

  • Potential legalization of cannabis in the U.S. and Europe.
  • Expansion into new markets and product categories.
  • Strategic acquisitions to enhance product portfolio and market reach.
  • Development of innovative cannabis-infused products.

Threats

  • Regulatory uncertainties and changes in cannabis laws.
  • Intense competition from established players and new entrants.
  • Fluctuations in cannabis prices and demand.
  • Economic downturns affecting consumer spending.

Competitive Advantages

  • Established brands in the cannabis and beverage alcohol sectors.
  • Strategic partnerships and distribution networks.
  • Diversified product portfolio across multiple segments.
  • GMP-certified production facilities.

About TLRY

Tilray Brands, Inc., headquartered in Leamington, Canada, is a global cannabis-lifestyle consumer packaged goods (CPG) company. Originally known as Tilray, Inc., the company has evolved through strategic mergers and acquisitions to become a diversified player in the cannabis, beverage alcohol, and wellness sectors. Tilray engages in the research, cultivation, production, marketing, and distribution of medical and adult-use cannabis products across Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. Its product offerings include GMP-certified flowers, oils, vapes, edibles, and topicals under brands like Tilray, Aphria, Broken Coast, and Good Supply. Beyond cannabis, Tilray has expanded into the beverage alcohol market with brands such as SweetWater and Breckenridge Distillery, and offers hemp-based food and wellness products. Tilray distributes its products through various channels, including retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, governments, and direct-to-consumers.

What They Do

  • Researches and develops medical cannabis products.
  • Cultivates and produces cannabis flowers, oils, and other extracts.
  • Manufactures and distributes adult-use cannabis products.
  • Produces, markets, and sells beverage alcohol products.
  • Offers hemp-based food and wellness products.
  • Sells products to retailers, wholesalers, and direct to consumers.

Business Model

  • Cultivation and production of cannabis products.
  • Distribution and sale of cannabis, beverage alcohol, and wellness products.
  • Revenue generation through wholesale and retail channels.
  • Strategic acquisitions to expand product portfolio and market reach.

Industry Context

Tilray operates within the dynamic and evolving cannabis and beverage alcohol industries. The global cannabis market is projected to experience substantial growth, driven by increasing legalization and acceptance of cannabis for medical and recreational use. The beverage alcohol market remains competitive, with established players and emerging craft brands vying for market share. Tilray's competitive positioning is strengthened by its diversified portfolio, which allows it to capitalize on growth opportunities in both sectors. Key competitors include other cannabis producers and established beverage alcohol companies. The company's success depends on its ability to navigate regulatory complexities, innovate with new products, and effectively market its brands to consumers.

Key Customers

  • Retailers and wholesalers of cannabis and beverage alcohol products.
  • Patients and physicians seeking medical cannabis products.
  • Consumers of adult-use cannabis and beverage alcohol products.
  • Hospitals and pharmacies.
AI Confidence: 72% Updated: Feb 5, 2026

Financials

Chart & Info

Tilray Brands, Inc. (TLRY) stock price: $6.54 (-0.40, -5.76%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TLRY.

Price Targets

Consensus target: $10.00

MoonshotScore

47/100

What does this score mean?

The MoonshotScore rates TLRY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

What Investors Ask About Tilray Brands, Inc. (TLRY)

What does Tilray Brands, Inc. do?

Tilray Brands, Inc. is a global cannabis-lifestyle CPG company that cultivates, produces, markets, and distributes medical and adult-use cannabis products across Canada, the United States, Europe, Australia, New Zealand, and Latin America. Beyond cannabis, Tilray has expanded into the beverage alcohol market with brands such as SweetWater and Breckenridge Distillery, and offers hemp-based food and wellness products. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. Tilray sells its products through various channels, including retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, governments, and direct-to-consumers.

Is TLRY stock worth researching?

TLRY stock presents a mixed investment profile. The company's strategic positioning in the growing cannabis and beverage alcohol markets, coupled with potential legalization catalysts, offers significant upside potential. However, current profitability challenges, as reflected in the negative profit margin of -252.6%, and high debt levels pose risks. Investors should carefully consider their risk tolerance and monitor the company's ability to execute its growth strategy, improve financial performance, and navigate regulatory uncertainties. A positive outlook hinges on successful expansion, cost management, and favorable regulatory developments.

What are the main risks for TLRY?

The main risks for Tilray include regulatory uncertainties and potential setbacks in cannabis legalization, which could limit market access and growth opportunities. Intense competition and price pressures in the cannabis market could erode profitability. Fluctuations in cannabis prices and demand, as well as economic downturns affecting consumer spending, could negatively impact revenue. Additionally, high debt levels and potential financial distress pose a significant risk to the company's financial stability. Investors should carefully monitor these risks and their potential impact on Tilray's performance.

What are the key factors to evaluate for TLRY?

Tilray Brands, Inc. (TLRY) currently holds an AI score of 47/100, indicating low score. Analysts target $10.00 (+53% from $6.54). Key strength: Diversified product portfolio across cannabis, beverage alcohol, and wellness.. Primary risk to monitor: Potential: Regulatory setbacks and delays in cannabis legalization.. This is not financial advice.

How frequently does TLRY data refresh on this page?

TLRY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven TLRY's recent stock price performance?

Recent price movement in Tilray Brands, Inc. (TLRY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $10.00 implies 53% upside from here. Notable catalyst: Diversified product portfolio across cannabis, beverage alcohol, and wellness.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider TLRY overvalued or undervalued right now?

Determining whether Tilray Brands, Inc. (TLRY) is overvalued or undervalued requires examining multiple metrics. Analysts target $10.00 (+53% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying TLRY?

Before investing in Tilray Brands, Inc. (TLRY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • The cannabis industry is subject to rapid regulatory changes, which could significantly impact Tilray's business.
  • Financial data is based on publicly available information and may be subject to change.
  • Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially.
Data Sources

Popular Stocks